P3 Health Partners Inc. (PIII)
NASDAQ: PIII · Real-Time Price · USD
11.38
+0.70 (6.51%)
At close: Jun 26, 2026, 4:00 PM EDT
11.31
-0.06 (-0.57%)
After-hours: Jun 26, 2026, 4:57 PM EDT
P3 Health Partners Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for P3 Health Partners stock have an average target of 488, with a low estimate of 14 and a high estimate of 962. The average target predicts an increase of 4,190.11% from the current stock price of 11.38.
Analyst Consensus: Buy
* Price targets were last updated on May 21, 2026.
Analyst Ratings
The average analyst rating for P3 Health Partners stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '25 | Nov '25 | Dec '25 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Hold Reiterates $3 → $14 | Hold | Reiterates | $3 → $14 | +23.08% | May 21, 2026 |
| Lake Street | Lake Street | Buy Reiterates $4 → $962 | Buy | Reiterates | $4 → $962 | +8,357.14% | May 15, 2026 |
Financial Forecast
Revenue This Year
1.52B
from 1.46B
Increased by 4.46%
Revenue Next Year
1.65B
from 1.52B
Increased by 8.03%
EPS This Year
n/a
EPS Next Year
n/a
Revenue Forecast
| Revenue | 2026 | 2027 |
|---|---|---|
| High | 1.5B | 1.7B |
| Avg | 1.5B | 1.6B |
| Low | 1.5B | 1.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 |
|---|---|---|
| High | 5.9% | 10.6% |
| Avg | 4.5% | 8.0% |
| Low | 3.0% | 5.4% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Growth
| EPS Growth | 2027 |
|---|---|
| High | - |
| Avg | - |
| Low | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.